Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review

The ovarian cancer recurrence occurs in 75% of patients with advanced FIGO stage, and its treatment is a challenge for the oncologist in gynecology. The standard treatment of recurrent ovarian cancer (ROC) usually includes intravenous chemotherapy according to platinum sensitivity. Furthermore, main...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Conte, Carmine, Fagotti, Anna, Avesani, Giacomo, Trombadori, Charlotte, Federico, Alex, D’Indinosante, Marco, Giudice, Maria Teresa, Pelligra, Silvia, Lodoli, Claudio, Marchetti, Claudia, Ferrandina, Gabriella, Scambia, Giovanni, Gallotta, Valerio
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039681/
https://ncbi.nlm.nih.gov/pubmed/33850907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4690
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars